How to select appropriate hemoglobin target levels on health-related quality of life and outcomes for patients with chronic kidney disease? by Filippo Salvati

Subjects: “…erythropoietin, erythropoiesis stimulating agents.…”
Get full text

Appropriate Use of Inpatient Erythropoiesis Stimulating Agents by Chenghao Cui, Timothy Nguyen, Mohammad Rattu

Subjects: Get full text

In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study by Ylenia Ingrasciotta, Viviana Lacava, Ilaria Marcianò, Francesco Giorgianni, Giovanni Tripepi, Graziella D’ Arrigo, Alessandro Chinellato, Daniele Ugo Tari, Domenico Santoro, Gianluca Trifirò

Subjects: Get full text

Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation by Yukiko Yasuoka, Takashi Fukuyama, Yuichiro Izumi, Yushi Nakayama, Hideki Inoue, Kengo Yanagita, Tomomi Oshima, Taiga Yamazaki, Takayuki Uematsu, Noritada Kobayashi, Yoshitaka Shimada, Yasushi Nagaba, Masashi Mukoyama, Tetsuro Yamashita, Yuichi Sato, Jeff M. Sands, Katsumasa Kawahara, Hiroshi Nonoguchi

Subjects: Get full text

The Effect of Erythropoiesis-Stimulating Agents on Platelet Aggregation in Peritoneal Dialysis Patients by Serkan Bakırdöğen, Necmi Eren, Sibel Gökçay Bek, Sara Yavuz

Subjects: Get full text

A possible contributor to erythropoiesis-stimulating agents requirement in hemodialysis: Paraoxonase 1 activity by Mehmet Kürşat Derici, Hasan Hacı, Berfu Korucu, Elif Burcu Bali, Galip Guz

Subjects: Get full text

Anemia of chronic diseases: the important aspects of pathogenesis and treatment by O. A. Rukavitsyn

Subjects: Get full text

Plasma erythropoietin level and heart failure in patients undergoing peritoneal dialysis: a cross-sectional study by Kohsuke Terada, Yuichiro Sumi, Sae Aratani, Akio Hirama, Tetsuya Kashiwagi, Yukinao Sakai

Subjects: Get full text

Hyporesponsiveness to long-acting erythropoiesis-stimulating agent is related to the risk of cardiovascular disease and death in Japanese patients on chronic hemodialysis: observat... by Kenichi Tanaka, Momoko Fujiwara, Hirotaka Saito, Tsuyoshi Iwasaki, Akira Oda, Shuhei Watanabe, Makoto Kanno, Hiroshi Kimura, Yoshihiro Tani, Jun Asai, Hodaka Suzuki, Keiji Sato, Junichiro James Kazama

Subjects: “…Erythropoiesis-stimulating agents…”
Get full text

Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients by Kristina Petrulienė, Edita Žiginskienė, Vytautas Kuzminskis, Irena Nedzelskienė, Inga Arūnė Bumblytė

Subjects: Get full text

Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients by Koike K, Fukami K, Kawaguchi A, Shimamatsu K, Yamagishi SI, Okuda S

Subjects: Get full text

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective by Matti Aapro, Pere Gascón, Kashyap Patel, George M. Rodgers, Selwyn Fung, Luiz H. Arantes, Jay Wish

Subjects: Get full text

Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options by Lewis R, Bewersdorf JP, Zeidan AM

Subjects: Get full text

Erythropoiesis-stimulating agents in chronic kidney disease: What have we learned in 25 years? by Szu-Chun Hung, Yao-Ping Lin, Der-Cherng Tarng

Subjects: Get full text

Obesity may be erythropoietin dose-saving in hemodialysis patients by Ghada M. El-Kannishy, Abir F. Megahed, Mona M. Tawfik, Ghada El-Said, Rabab T. Zakaria, Nahed A. Mohamed, Eman M. Taha, Alzhraa A. Ammar, Abeer M. Abd Eltawab, Nagy A. Sayed-Ahmed

Subjects: Get full text

Effect of long period treatment with erythropoiesis stimulating agents on clinically and laboratory parameters in hemodialysis autosomal dominant polycystic kidney disease patients by Orăsan Olga Hilda, Petrov Ljubomir, Urian Laura, Cozma Angela, Ciulei George, Patiu Ioan Mihai, Orăsan Remus Aurel

Subjects: Get full text

High dose ESAs are associated with high iPTH levels in hemodialysis patients with end-stage kidney disease: a retrospective analysis by Lan eChen, Yi-sheng eLing, Chun-hua eLin, Jin-Xuan eHe, Tian-Jun eGuan

Subjects: Get full text

Cancer, meta-analysis and reporting biases: the case of erythropoiesis-stimulating agents by Thomy Tonia, Guido Schwarzer, Julia Bohlius

Subjects: Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1 by Alberto Martínez-Castelao, Aleix Cases, Alberto Torre Carballada, Javier Torralba Iranzo, Josep Bronsoms, Martí Vallès-Prats, Daniel Torán Monserrat, Elisabet Masso Jimenez

Subjects: Get full text

Hemoglobin and Clinical Outcomes in Hemodialysis: An Analysis of US Medicare Data From 2018 to 2020Plain-Language Summary by Eric W. Young, Dongyu Wang, Alissa Kapke, Jeffrey Pearson, Marc Turenne, Bruce M. Robinson, Edwin D. Huff

Subjects: Get full text